Dogwood Therapeutics Inc.

DWTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.63

+$0.03 (+1.87%)

Sep 22, 2026, 12:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-34.26M	-12.35M	-5.3M	-12.25M	-15.96M	-10.35M
Depreciation & Amortization	2.06K	12.18K	n/a	n/a	n/a	n/a
Stock-Based Compensation	355.64K	476.02K	619.97K	582.66K	322.88K	7.43M
Other Working Capital	399.6K	-801.16K	266.81K	-21.92K	-322.2K	-1.03M
Other Non-Cash Items	18.19M	3.65M	n/a	n/a	n/a	-4.26K
Deferred Income Tax	221.1K	-503	n/a	n/a	n/a	n/a
Change in Working Capital	-133K	-581.27K	-194.45K	197.38K	-52.19K	-974.06K
Operating Cash Flow	-15.62M	-8.79M	-4.87M	-11.47M	-15.69M	-3.9M
Capital Expenditures	n/a	5	n/a	-3	n/a	-5
Cash Acquisitions	n/a	3.76M	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	3.76M	n/a	n/a	n/a	n/a
Debt Repayment	3M	15.32M	n/a	n/a	n/a	1.99M
Common Stock Repurchased	n/a	-351	n/a	n/a	-295.17K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-75K
Other Financial Acitivies	-53.81K	n/a	n/a	n/a	197.56K	112.99K
Financial Cash Flow	7.28M	16.7M	1.16M	4.49M	-97.6K	33.38M
Net Cash Flow	-8.32M	11.53M	-3.71M	-6.98M	-15.79M	29.49M
Free Cash Flow	-15.62M	-8.79M	-4.87M	-11.47M	-15.69M	-3.9M
Adj. Free Cash Flow	-15.97M	-9.27M	-5.49M	-12.05M	-16.01M	-11.32M
Maintenance CapEx	n/a	-5	n/a	n/a	n/a	n/a
Growth CapEx	n/a	10	n/a	-3	n/a	-5
Owner Earnings	-15.62M	-8.79M	-4.87M	-11.47M	-15.69M	-3.9M